Cadence Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-36,821
| Closed | -$1.15M | – | 697 |
|
|
2017
Q1 | $1.15M | Sell |
36,821
-14,315
| -28% | -$448K | 0.08% | 304 |
|
|
2016
Q4 | $1.29M | Sell |
51,136
-2,351
| -4% | -$59.4K | 0.09% | 277 |
|
|
2016
Q3 | $1.32M | Buy |
53,487
+3,227
| +6% | +$79.8K | 0.1% | 248 |
|
|
2016
Q2 | $1.02M | Sell |
50,260
-1,105
| -2% | -$22.5K | 0.08% | 285 |
|
|
2016
Q1 | $783K | Sell |
51,365
-8,780
| -15% | -$134K | 0.06% | 363 |
|
|
2015
Q4 | $808K | Buy |
60,145
+10,917
| +22% | +$147K | 0.05% | 361 |
|
|
2015
Q3 | $691K | Buy |
+49,228
| New | +$691K | 0.05% | 398 |
|
|
2015
Q2 | – | Sell |
-111,020
| Closed | -$1.34M | – | 662 |
|
|
2015
Q1 | $1.34M | Buy |
111,020
+1,030
| +0.9% | +$12.5K | 0.08% | 315 |
|
|
2014
Q4 | $913K | Buy |
+109,990
| New | +$913K | 0.05% | 429 |
|